India's Largest Database on New Projects
Malaysia nod to Stempeutics drug trials
19 April 2011: The Manipal Group owned Stempeutics Research has received the green signal from the Malaysian regulator for conducting Phase I and II clinical trials of its novel candidate drug to treat osteoarthritis and cerebral stroke.
Stempeutics is expected to launch the first stem cell-based drug off the shelf in Malaysia in 2014. This is the first Indian stem cell product to be tested in Malaysia, the Bengaluru based Stempeutics, funded by Manipal Education & Medical Group and CIPLA.
The company has also planned for a large-scale upscaling of mesenchymal stem cells facility in Malaysia. Apart from large facilities in Bengaluru and Manipal (Karnataka), the company had set up Stempeutics Malaysia in 2007 and a large facility to produce mesenchymal stem cells from donated bone marrow. It has filed six patents in Malaysia.
Source: Hindu Business Line